STOCK TITAN

Macerich Announces Commencement of Public Offering of Common Stock

(Positive)
Tags

Macerich (NYSE: MAC) commenced an underwritten public offering of 14,000,000 common shares using forward sale agreements, with a 30-day option for underwriters to buy up to 2,100,000 additional shares.

The company expects to physically settle by June 16, 2027 and plans to use any net proceeds for future acquisitions and general corporate purposes.

Loading...
Loading translation...

Positive

  • Forward sale agreements for 14,000,000 shares provide flexibility in timing equity issuance
  • Underwriters’ 30-day option for 2,100,000 additional shares can increase available growth capital
  • Proceeds upon settlement are earmarked for future acquisitions and general corporate purposes

Negative

  • Future issuance of up to 16,100,000 shares may dilute existing shareholders
  • Company will not initially receive any cash proceeds from the offering
  • Settlement may occur as late as June 16, 2027, delaying access to equity capital

News Market Reaction – MAC

-5.34% 2.7x vol
12 alerts
-5.34% Session close to close
$7.11B Market Cap
2.7x Rel. Volume

In the Jun 16 session, MAC declined 5.34%, reflecting a notable negative market reaction. Our momentum scanner triggered 12 alerts that day, indicating notable trading interest and price volatility. Trading volume was elevated at 2.7x the daily average, suggesting increased selling activity.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved -5.3% in the session following this news. A negative reaction despite the company’s ...
Analysis

The stock moved -5.3% in the session following this news. A negative reaction despite the company’s history of modestly positive moves after offerings would contrast with the prior average next‑day move of about +2.88%. The announcement involves up to 16.1 million additional shares through forward sale agreements, which increases dilution risk and can pressure valuation. If the planned acquisitions or general corporate uses do not clearly enhance earnings power over time, dilution concerns could continue to weigh on sentiment.

Key Figures

Base offering size: 14,000,000 shares Underwriters’ option: 2,100,000 shares Maximum settlement shares: 16,100,000 shares +5 more
8 metrics
Base offering size 14,000,000 shares Common stock in new underwritten public offering via forward sale agreements
Underwriters’ option 2,100,000 shares 30-day option to purchase additional common shares
Maximum settlement shares 16,100,000 shares Total shares if underwriters’ option is fully exercised
Settlement deadline June 16, 2027 Latest date for physical settlement of forward sale agreements
Forward sale tranches 14,000,000 shares Shares subject to forward sale agreements with forward purchasers
Current share price $25.45 Price before this offering announcement
52-week high $25.59 Pre-news 52-week high level
Market cap $7,214,087,209 Equity value prior to new offering

Previous Offering Reports

4 past events · Latest: May 11 (Neutral)
Same Type Pattern 4 events
Date Event Sentiment 24h Move Catalyst
May 11 Offering pricing Neutral +2.8% Priced upsized 19.2M-share offering at $21.00 with 2.88M-share option.
May 11 Offering launch Neutral +2.8% Announced 16M-share common stock offering with 2.4M-share underwriter option.
Nov 26 Offering pricing Neutral +3.0% Priced upsized 20M-share offering at $19.75 to raise about $395M.
Nov 25 Offering launch Neutral +3.0% Announced 18M-share offering plus 2.7M-share option to repay $478M loan.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent common stock offerings have been followed by modestly positive next-day moves around +2–3%, suggesting prior equity raises were absorbed constructively.

Recent Company History

Over the past two years, Macerich has repeatedly accessed equity markets via common stock offerings, often upsized, with average next‑day moves around +2.88%. November 2024 and May 2026 offerings funded repayment of a $478 million high‑rate mortgage and revolver borrowings tied to the Annapolis Mall acquisition, as well as general corporate and leasing investments. Today’s announcement continues that pattern of using equity issuance to support balance sheet and property strategies.

Key Terms

underwritten public offering, forward sale agreement, forward purchasers, prospectus supplement, +4 more
8 terms
underwritten public offering financial
"it has commenced an underwritten public offering of 14,000,000 shares of common stock"
An underwritten public offering is when a company sells new shares of its stock to the public with the help of a financial firm, called an underwriter. The underwriter agrees to buy all the shares upfront, reducing the company's risk, and then sells them to investors. This process helps companies raise money quickly and confidently from a wide range of buyers.
forward sale agreement financial
"in connection with the forward sale agreement described below"
A forward sale agreement is a contract where a holder of securities or assets agrees to sell them at a fixed price on a specific future date, like a farmer locking in a price for next season’s crop. For investors this matters because it creates predictable future cash or supply and reduces price uncertainty, but it can limit upside if prices rise and introduces risk if the other party fails to deliver or payment affects shareholder value through dilution or financing choices.
forward purchasers financial
"one or more other financial institutions (the "forward purchasers")"
Forward purchasers are investors or firms who agree ahead of time to buy a specific number of securities or assets at a set price on a future date, similar to placing a pre-order for a product that will ship later. They matter to investors because these commitments provide predictable demand and funding for the issuer, but they can also affect share supply and pricing when the agreed sales are fulfilled, influencing market value and dilution risk.
prospectus supplement regulatory
"Copies of the preliminary prospectus supplement and accompanying prospectus"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
registration statement regulatory
"effective registration statement relating to these securities"
A registration statement is a formal document that companies file with a government agency to offer new shares of stock to the public. It provides essential information about the company's finances, operations, and risks, helping investors make informed decisions. Think of it as a detailed product description that ensures transparency and trust before buying into a company.
net share settlement financial
"Subject to its right to elect cash or net share settlement, which right is subject"
Net share settlement is a way of paying for financial transactions using only the difference in shares rather than exchanging full amounts of stock or cash. It’s like settling a debt by giving someone the exact number of shares needed to balance the books, making trades quicker and simpler. This method helps reduce the number of shares changing hands, saving time and costs.
bookrunner financial
"Goldman Sachs & Co. LLC is serving as the lead bookrunner and representative"
A bookrunner is the lead bank or financial firm that organizes and manages a new securities offering, acting like a project manager who sets the price range, collects investor demand, and decides how shares are allocated. For investors, the bookrunner’s choices and reputation influence the final price, how many shares each buyer receives, and the overall chance the deal succeeds — similar to how a trusted referee shapes a fair and well-run auction.
short-term, interest-bearing deposit accounts financial
"may invest the net proceeds in short-term, interest-bearing deposit accounts"
Accounts that hold cash for a short period while paying interest, combining easy access with modest returns. Think of them as a safe short-term parking spot for money where it can earn a little “rent” instead of sitting idle; they matter to investors because they let portfolios keep cash ready for opportunities or obligations without taking on the risk or commitment of long-term investments, while offering a predictable, low-risk income stream.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

SANTA MONICA, Calif., June 15, 2026 (GLOBE NEWSWIRE) -- The Macerich Company (NYSE: MAC) (the “Company” or “Macerich”) announced today that it has commenced an underwritten public offering of 14,000,000 shares of common stock in connection with the forward sale agreement described below. Goldman Sachs & Co. LLC is serving as the lead bookrunner and representative of the underwriters of the offering. In connection with the offering, the Company intends to grant the underwriters a 30-day option to purchase up to an additional 2,100,000 shares of common stock.

The Company expects to enter into a forward sale agreement with each of Goldman Sachs & Co. LLC or its affiliates, and one or more other financial institutions (the "forward purchasers"), with respect to 14,000,000 shares of the Company's common stock. In connection with the forward sale agreement, the forward purchasers or their affiliates are expected to borrow and sell to the underwriters an aggregate of 14,000,000 shares of the common stock that will be delivered in the offering. Subject to its right to elect cash or net share settlement, which right is subject to certain conditions, the Company intends to deliver, upon physical settlement of such forward sale agreements on one or more dates specified by the Company occurring no later than June 16, 2027 an aggregate of 14,000,000 shares of its common stock (or an aggregate of 16,100,000 shares of common stock if the underwriters exercise their option to purchase additional shares in full) to the forward purchasers in exchange for cash proceeds per share equal to the applicable forward sale price, subject to certain adjustments as provided in the forward sale agreements.

The Company will not initially receive any proceeds from the sale of shares of its common stock by the forward purchasers or their affiliates in the offering. The Company intends to use the net proceeds, if any, it receives upon the future settlement of the forward sale agreements to fund future acquisition opportunities and for general corporate purposes. Pending such use, the Company may invest the net proceeds in short-term, interest-bearing deposit accounts.

Selling common stock through the forward sale agreements enables the Company to set the price of such shares upon the pricing of the offering (subject to certain adjustments) while delaying the issuance of such shares and the receipt of the net proceeds by the Company until a time closer to the funding requirements described above.

Copies of the preliminary prospectus supplement and accompanying prospectus relating to these securities may be obtained, when available, by contacting: Goldman Sachs & Co. LLC, Prospectus Department, 200 West Street, New York, NY 10282, telephone: 1-866-471-2526, facsimile: 212-902-9316 or by email at Prospectus-ny@ny.email.gs.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities of the Company, nor shall there be any sale of such securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. Any such offer or sale will be made only by means of the prospectus supplement and prospectus forming part of the effective registration statement relating to these securities.

About the Company

Macerich (NYSE: MAC) is a fully integrated, self-managed, self-administered real estate investment trust (REIT). As a leading owner, operator, and developer of high-quality retail real estate in densely populated and attractive U.S. markets, Macerich’s portfolio is concentrated in California, the Pacific Northwest, Phoenix/Scottsdale, and the Metro New York to Washington, D.C. corridor. Developing and managing properties that serve as community cornerstones, Macerich currently owns approximately 41 million square feet of real estate, consisting primarily of interests in 39 retail centers.

Forward-Looking Information

Information set forth in this press release contains “forward-looking statements” (within the meaning of the federal securities laws, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended), which reflect the Company’s expectations regarding future events and plans, including, but not limited to, statements regarding the Company’s potential grant to the underwriters of an option to purchase additional shares of common stock and the Company’s anticipated use of net proceeds from the offering. Generally, the words “expects,” “anticipates,” “projects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “scheduled,” “predicts,” “may,” “will,” “should,” “could,” variations of such words and similar expressions identify forward-looking statements. The forward-looking statements are based on information currently available to us and involve a number of known and unknown assumptions, risks, uncertainties and other factors, which may be difficult to predict and beyond the control of the Company, which could cause actual results to differ materially from those contained in the forward-looking statements. These factors include the risks and uncertainties detailed from time to time in the Company’s filings with the Securities and Exchange Commission (the “SEC”), which are available at the SEC’s website at www.sec.gov. The Company disclaims any obligation to publicly update or revise any forward-looking statements contained in this press release whether as a result of changes in underlying assumptions or factors, new information, future events or otherwise, except as required by law.

INVESTOR CONTACT: Investor Relations, IR@macerich.com


FAQ

What did Macerich (NYSE: MAC) announce on June 15, 2026 about its stock offering?

Macerich announced an underwritten public offering of 14,000,000 common shares tied to forward sale agreements. According to Macerich, the deal includes a 30-day option for underwriters to purchase up to 2,100,000 additional shares, potentially increasing total shares issued to 16,100,000.

How many Macerich (MAC) shares are included in the June 2026 forward sale offering?

The offering covers 14,000,000 Macerich common shares under forward sale agreements. According to Macerich, underwriters may also buy up to 2,100,000 additional shares within 30 days, bringing the potential total to 16,100,000 shares upon full exercise and settlement.

When will Macerich (MAC) receive proceeds from the June 2026 stock offering?

Macerich will receive cash only upon future settlement of the forward sale agreements, not at launch. According to Macerich, physical settlement may occur on one or more dates chosen by the company, no later than June 16, 2027, subject to settlement election conditions.

How does the June 2026 Macerich (MAC) forward sale agreement work for this stock offering?

Forward purchasers or affiliates will borrow and sell 14,000,000 shares to underwriters at offering pricing. According to Macerich, the company later intends to deliver shares upon physical settlement in exchange for cash based on the applicable forward sale price, subject to specified adjustments.

What will Macerich (MAC) use the proceeds from its June 2026 common stock offering for?

Macerich plans to use any net proceeds from future forward settlement to fund acquisition opportunities and general corporate purposes. According to Macerich, pending deployment, the company may invest proceeds in short-term, interest-bearing deposit accounts to preserve liquidity and earn interim returns.

Does the June 2026 Macerich (MAC) stock offering immediately dilute shareholders?

The transaction uses forward sale agreements, so new shares are delivered at future settlement rather than immediately. According to Macerich, up to 16,100,000 shares may ultimately be issued upon physical settlement, which would increase the share count and impact ownership percentages.